Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy
Bryostatin 1 is a unique therapeutic lead, however its scarce natural sources have hampered its use in treatment of human disease. Here, the authors use a scalable synthesis of bryostatin 1 to make close-in analogs which potently induce increased cell surface expression holding potential for immunot...
Main Authors: | Clayton Hardman, Stephen Ho, Akira Shimizu, Quang Luu-Nguyen, Jack L. Sloane, Mohamed S. A. Soliman, Matthew D. Marsden, Jerome A. Zack, Paul A. Wender |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-04-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-15742-7 |
Similar Items
-
HIV latency reversal using designed PKC modulators
by: M.D. Marsden, et al.
Published: (2017-12-01) -
Barcoded HIV reveals effects of PKC modulation on viral reservoir
by: J. Zack, et al.
Published: (2019-12-01) -
Evaluation of HIV latency reversal using designed PKC modulators in humanized BLT mice
by: M.D. Marsden, et al.
Published: (2015-12-01) -
Retrosynthetic Reaction Prediction Using Neural Sequence-to-Sequence Models
by: Bowen Liu, et al.
Published: (2017-09-01) -
Glucosamine Modulation of PKC-induced Inflammation in Osteosarcoma Cells
by: Chuan Chen, et al.
Published: (2016)